NO975977L - Substituted purine derivatives, processes for their preparation and use - Google Patents

Substituted purine derivatives, processes for their preparation and use

Info

Publication number: NO975977L
Authority: NO; Norway
Prior art keywords: processes; preparation; purine derivatives; substituted purine; substituted
Prior art date: 1996-12-20

Application number

NO975977A

Other languages

Norwegian (no)

Other versions

NO314583B1 (en

NO975977D0 (en

Inventor

Anuschirwan Peyman

Jochen Knolle

Volkmar Wehner

Gerhard Breipohl

Jean-Fran Ois Gourvest

Denis Carniato

Thomas Richard Gadek

Original Assignee

Hoechst Ag

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1997-12-19

Publication date

1998-06-22

1997-12-19 Application filed by Hoechst Ag, Genentech Inc filed Critical Hoechst Ag

1997-12-19 Publication of NO975977D0 publication Critical patent/NO975977D0/en

1998-06-22 Publication of NO975977L publication Critical patent/NO975977L/en

2003-04-14 Publication of NO314583B1 publication Critical patent/NO314583B1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO19975977A 1996-12-20 1997-12-19 Substituted purine derivatives, methods of preparation and pharmaceutical compositions containing them NO314583B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19653646A DE19653646A1 (en)	1996-12-20	1996-12-20	Substituted purine derivatives, processes for their preparation, agents containing them and their use

Publications (3)

Publication Number	Publication Date
NO975977D0 NO975977D0 (en)	1997-12-19
NO975977L true NO975977L (en)	1998-06-22
NO314583B1 NO314583B1 (en)	2003-04-14

Family

ID=7815761

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19975977A NO314583B1 (en)	1996-12-20	1997-12-19	Substituted purine derivatives, methods of preparation and pharmaceutical compositions containing them

Country Status (21)

Country	Link
EP (1)	EP0853084B1 (en)
JP (1)	JP4620190B2 (en)
KR (1)	KR19980064655A (en)
CN (2)	CN1101816C (en)
AR (1)	AR010700A1 (en)
AT (1)	ATE404562T1 (en)
AU (1)	AU728865B2 (en)
BR (1)	BR9706387A (en)
CA (1)	CA2225366C (en)
CZ (1)	CZ294437B6 (en)
DE (2)	DE19653646A1 (en)
HU (1)	HUP9702507A3 (en)
ID (1)	ID19254A (en)
IL (1)	IL122642A0 (en)
NO (1)	NO314583B1 (en)
NZ (1)	NZ329431A (en)
PL (1)	PL323969A1 (en)
RU (1)	RU2228335C2 (en)
TR (1)	TR199701647A2 (en)
TW (1)	TW523515B (en)
ZA (1)	ZA9711317B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999052872A1 (en)	1998-04-09	1999-10-21	Meiji Seika Kaisha, Ltd.	AMINOPIPERIDINE DERIVATIVES AS INTEGRIN αvβ3 ANTAGONISTS
EP1140194A2 (en)	1998-12-23	2001-10-10	G.D. SEARLE & CO.	Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
JP3270834B2 (en)	1999-01-27	2002-04-02	ファイザー・プロダクツ・インク	Heteroaromatic bicyclic derivatives useful as anticancer agents
UA71945C2 (en)	1999-01-27	2005-01-17	Pfizer Prod Inc	Substituted bicyclic derivatives being used as anticancer agents
EP1065207A1 (en)	1999-07-02	2001-01-03	Aventis Pharma Deutschland GmbH	Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
EP1065208A1 (en)	1999-07-02	2001-01-03	Aventis Pharma Deutschland GmbH	Substituted purine derivatives as inhibitors of cell adhesion
AU6316900A (en)	1999-08-05	2001-03-05	Meiji Seika Kaisha Ltd.	Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alphavbeta3antagonism
EP1176145A1 (en) *	2000-07-28	2002-01-30	Aventis Pharma Deutschland GmbH	Novel guanidino derivatives as inhibitors of cell adhesion
DE10042655A1 (en) *	2000-08-31	2002-03-14	Aventis Pharma Gmbh	Process for the preparation of inhibitors of cell adhesion
KR100438820B1 (en) *	2001-03-05	2004-07-05	삼성코닝 주식회사	Method for manufacturing compound semiconductor substrate of III-V group
EP1381384B1 (en)	2001-04-24	2011-05-25	Merck Patent GmbH	COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha
FR2847254B1 (en) *	2002-11-19	2005-01-28	Aventis Pharma Sa	NOVEL VITRONECTIN RECEPTOR ANTAGONIST DERIVATIVES, PROCESS FOR PREPARING THEM, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS REFLECTING THEM
FR2870541B1 (en)	2004-05-18	2006-07-14	Proskelia Sas	ANTIGONISTIC PYRIMIDINE DERIVATIVES OF VITRONECTIN RECEPTOR
UA87854C2 (en)	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
ES2521679T3 (en)	2006-01-18	2014-11-13	Merck Patent Gmbh	Specific therapy using integrin ligands for cancer treatment
WO2008087025A2 (en)	2007-01-18	2008-07-24	Merck Patent Gmbh	Specific therapy and medicament using integrin ligands for treating cancer
RU2475499C2 (en)	2007-10-11	2013-02-20	Дайити Санкио Компани, Лимитед	Antibody directed on siglec-15 protein, bound with osteoclasts
JP2011503206A (en) *	2007-11-14	2011-01-27	ミレクシス，インコーポレイテッド	Therapeutic compounds and methods of use thereof in the treatment of diseases and disorders
CN106317224B (en)	2009-04-09	2020-05-12	第一三共株式会社	anti-Siglec-15 antibodies
NZ597339A (en)	2009-05-25	2013-10-25	Merck Patent Gmbh	Continuous administration of cilengitide in cancer treatments
KR20130066682A (en)	2010-10-05	2013-06-20	다이이찌 산쿄 가부시키가이샤	Antibody targeting osteoclast-related protein siglec-15
SG11201405966PA (en)	2012-03-30	2014-11-27	Daiichi Sankyo Co Ltd	Cdr-modified anti-siglec-15 antibody
CN103665043B (en)	2012-08-30	2017-11-10	江苏豪森药业集团有限公司	A kind of tenofovir prodrug and its application in medicine
KR20160147007A (en)	2014-05-30	2016-12-21	화이자 인코포레이티드	Carbonitrile derivatives as selective androgen receptor modulators
WO2023275715A1 (en)	2021-06-30	2023-01-05	Pfizer Inc.	Metabolites of selective androgen receptor modulators
WO2024127350A1 (en)	2022-12-16	2024-06-20	Astrazeneca Ab	2,6,9-trisubstituted purines

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4730696Y1 (en) *	1966-12-10	1972-09-13
SU896875A1 (en) *	1979-11-27	1995-01-09	Ленинградский химико-фармацевтический институт	Method of obtaining 9-bromadenine
JPS6396663A (en) *	1986-10-13	1988-04-27	Mita Ind Co Ltd	Electrostatic charge image developing toner
JPS6396553A (en) *	1986-10-14	1988-04-27	Sekisui Chem Co Ltd	Packing material
DE4129603A1 (en) *	1991-09-06	1993-03-11	Thomae Gmbh Dr K	CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS
MX9207334A (en) *	1991-12-18	1993-08-01	Glaxo Inc	NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM
FR2700337B1 (en) *	1993-01-11	1995-04-14	Lafon Labor	Imidazopyridine-2-one derivatives, their preparation process and their use in therapy.
US6133444A (en) *	1993-12-22	2000-10-17	Perseptive Biosystems, Inc.	Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
DE4405378A1 (en) *	1994-02-19	1995-08-24	Merck Patent Gmbh	Adhesion receptor antagonists
US5554746A (en) *	1994-05-16	1996-09-10	Isis Pharmaceuticals, Inc.	Lactam nucleic acids
US5929046A (en) *	1994-06-08	1999-07-27	Cancer Research Campaign Technology Limited	Pyrimidine and purine derivatives and their use in treating tumour cells
US5994361A (en) *	1994-06-22	1999-11-30	Biochem Pharma	Substituted purinyl derivatives with immunomodulating activity
PL318199A1 (en) *	1994-06-29	1997-05-26	Smithkline Beecham Corp	Antagonists of vitronectin receptors
US5525606A (en) *	1994-08-01	1996-06-11	The United States Of America As Represented By The Department Of Health And Human Services	Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
AU4729796A (en) *	1994-12-28	1996-07-19	Peter E. Nielsen	Peptide nucleic acid incorporating a chiral backbone
US5977061A (en) *	1995-04-21	1999-11-02	Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic	N6 - substituted nucleotide analagues and their use
DE69632324T2 (en) *	1995-06-07	2005-06-16	PerSeptive Biosystems, Inc., Framingham	PNA-DNA CHIMESES AND PNA SYNTHESES FOR THEIR PREPARATION
JPH1025294A (en) *	1996-03-26	1998-01-27	Akira Matsuda	Fused heterocyclic derivative, method for producing the same, and therapeutic agent for malignant tumor containing the same
AU725254B2 (en) *	1996-03-26	2000-10-12	Du Pont Pharmaceuticals Company	Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives
GB9613021D0 (en) *	1996-06-21	1996-08-28	Pharmacia Spa	Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
EP0960121B1 (en) *	1996-07-24	2005-11-30	BUCHARDT, Dorte	Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US5866702A (en) *	1996-08-02	1999-02-02	Cv Therapeutics, Incorporation	Purine inhibitors of cyclin dependent kinase 2

1996
- 1996-12-20 DE DE19653646A patent/DE19653646A1/en not_active Withdrawn
1997
- 1997-12-12 EP EP97121930A patent/EP0853084B1/en not_active Expired - Lifetime
- 1997-12-12 AT AT97121930T patent/ATE404562T1/en not_active IP Right Cessation
- 1997-12-12 DE DE59712958T patent/DE59712958D1/en not_active Expired - Lifetime
- 1997-12-17 ZA ZA9711317A patent/ZA9711317B/en unknown
- 1997-12-17 BR BR9706387-8A patent/BR9706387A/en not_active Application Discontinuation
- 1997-12-18 AR ARP970105996A patent/AR010700A1/en unknown
- 1997-12-18 ID IDP973919A patent/ID19254A/en unknown
- 1997-12-18 NZ NZ329431A patent/NZ329431A/en unknown
- 1997-12-18 IL IL12264297A patent/IL122642A0/en unknown
- 1997-12-18 CZ CZ19974114A patent/CZ294437B6/en not_active IP Right Cessation
- 1997-12-18 AU AU48466/97A patent/AU728865B2/en not_active Ceased
- 1997-12-18 TR TR97/01647A patent/TR199701647A2/en unknown
- 1997-12-19 CN CN97107287A patent/CN1101816C/en not_active Expired - Fee Related
- 1997-12-19 CA CA002225366A patent/CA2225366C/en not_active Expired - Lifetime
- 1997-12-19 CN CNA031009328A patent/CN1495184A/en active Pending
- 1997-12-19 RU RU97121235/04A patent/RU2228335C2/en not_active IP Right Cessation
- 1997-12-19 NO NO19975977A patent/NO314583B1/en unknown
- 1997-12-19 HU HU9702507A patent/HUP9702507A3/en unknown
- 1997-12-20 KR KR1019970073883A patent/KR19980064655A/en not_active Ceased
- 1997-12-20 PL PL97323969A patent/PL323969A1/en unknown
- 1997-12-22 JP JP36553097A patent/JP4620190B2/en not_active Expired - Lifetime
1998
- 1998-02-11 TW TW086119133A patent/TW523515B/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0853084A2 (en)	1998-07-15
CZ294437B6 (en)	2005-01-12
CN1101816C (en)	2003-02-19
AR010700A1 (en)	2000-06-28
NZ329431A (en)	2000-01-28
HU9702507D0 (en)	1998-03-02
ATE404562T1 (en)	2008-08-15
NO314583B1 (en)	2003-04-14
AU4846697A (en)	1998-06-25
MX9710277A (en)	1998-10-31
CA2225366C (en)	2006-10-10
TR199701647A3 (en)	1998-07-21
CN1495184A (en)	2004-05-12
NO975977D0 (en)	1997-12-19
HK1012190A1 (en)	1999-07-30
CZ411497A3 (en)	1998-07-15
TW523515B (en)	2003-03-11
HUP9702507A2 (en)	1999-05-28
DE59712958D1 (en)	2008-09-25
AU728865B2 (en)	2001-01-18
ZA9711317B (en)	1998-06-22
TR199701647A2 (en)	1998-07-21
JPH10182645A (en)	1998-07-07
JP4620190B2 (en)	2011-01-26
CN1193623A (en)	1998-09-23
EP0853084B1 (en)	2008-08-13
EP0853084A3 (en)	1998-09-09
PL323969A1 (en)	1998-06-22
CA2225366A1 (en)	1998-06-20
BR9706387A (en)	2000-03-14
ID19254A (en)	1998-06-28
KR19980064655A (en)	1998-10-07
DE19653646A1 (en)	1998-06-25
IL122642A0 (en)	1998-08-16
RU2228335C2 (en)	2004-05-10
HUP9702507A3 (en)	1999-12-28

Publication	Publication Date	Title
NO975977D0 (en)	1997-12-19	Substituted purine derivatives, processes for their preparation and use
NO963015L (en)	1996-09-09	Tetracyclic derivatives, process for preparation and use
NO20012158D0 (en)	2001-05-02	Substituted 2-phenylbenzimidazoles, process for preparation and use thereof
NO980720D0 (en)	1998-02-20	Pyridazine-3-one derivatives, their use and intermediates for their preparation
IS4785A (en)	1998-06-26	Triazole derivatives, useful in treatment
EE04721B1 (en)	2006-10-16	Phenylxanthine derivatives, processes for their preparation and use
FI955235A7 (en)	1996-05-03	Oxazolidinion derivatives, their preparation and use
CY2013003I1 (en)	2014-07-02	PHOSPHONOCHEMICAL DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF
NO984516L (en)	1998-09-28	6-phenylpyridyl-2-amine derivatives
IS2076B (en)	2006-02-15	Acyl-piperazinil-pyrimidine derivatives, their preparation and use as pharmaceuticals
DK0832104T3 (en)	2003-01-06	Dolastatin derivatives, their preparation and use
DK1015444T3 (en)	2003-08-18	Pyrimidine derivatives and processes for their preparation
DK0915845T3 (en)	2002-01-07	Acryloyl-substituted distamycin derivatives, process for their preparation and use as antitumor and antiviral agents
ATE246199T1 (en)	2003-08-15	3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES
NO985307L (en)	1999-01-12	Distamycin derivatives, processes for their preparation, and their use
DK0675133T3 (en)	2000-04-25	13-Substituted milbemycin derivatives, their preparation and their use
DK1025100T3 (en)	2002-05-06	3-substituted tetrahydropyridopyrimidinone derivatives, their preparation and their use
DE69524611D1 (en)	2002-01-24	Pyrimidone DERIVATIVES
EE9800333A (en)	1999-04-15	Novel furanarylmethylidene derivatives, methods for their preparation and use in therapy
DE69724941D1 (en)	2003-10-23	Aminopyridine DERIVATIVES
NO20003268D0 (en)	2000-06-22	Hyperhydrated chiticoline, method and use
NO984921D0 (en)	1998-10-22	Tienopyridine derivatives and their use
SI0863139T1 (en)	2001-06-30	Benzoxazindione derivatives, process for their preparation and their use
ATE193300T1 (en)	2000-06-15	14ALPHA,17ALPHA-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES
FI964468A7 (en)	1996-11-06	Adenosine derivatives